FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma is a research paper published in Oncogene (2021). On theSindex it has a DataRank of 0.510. It has been cited 29 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.510
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →U.S. Department of Health & Human Services | National Institutes of Health
Grant: R01HL132849
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
Grant: R01HL141174
NHLBI NIH HHS
Grant: R01 HL158659
NHLBI NIH HHS
Grant: R56 HL126660
NCI NIH HHS
Grant: R01 CA142724
NHLBI NIH HHS
Grant: R01 HL152973
NHLBI NIH HHS
Grant: R01 HL149631
NHLBI NIH HHS
Grant: U01 HL148856
FWCI
3.01
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals